-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Upgrades Abivax to Buy, Raises Price Target to $158

Benzinga·06/30/2026 20:16:13
Listen to the news
Jefferies analyst Faisal Khurshid upgrades Abivax (NASDAQ:ABVX) from Hold to Buy and raises the price target from $108 to $158.